NewslettersHematopoiesis News Small Molecule SUMO Inhibition for Biomarker-Informed B Cell Lymphoma Therapy By lbeveridge - September 26, 2022 0 Researchers reported that activated MYC signaling was an actionable molecular vulnerability in vitro and in a pre-clinical murine in vivo model of MYCdriven B cell lymphoma. [Haematologica] Abstract